Posted on by Speer

WORKSHOPS
FRIDAY, OCTOBER 1, 2021

  815WORKSHOP I

CARDIOPULMONARY TRANSITION, POSTNATAL STABILIZATION
AND EMERGENCIES
Chair: O.D. Saugstad, Oslo, Norway; D. Singer, Hamburg, Germany

• Monitoring stabilization/resuscitation at birth
   A.B. te Pas, Leiden, The Netherlands

• Neonatal resuscitation guidelines: Scientific rationale and evidence
   O.D. Saugstad, Oslo, Norway

• Reversing the irreversible? Interactions between hypoxia and hypothermia in the perinatal period
   D. Singer, Hamburg, Germany

  945Interactive Discussion


1015Coffee Break


1045WORKSHOP II

RDS AND SURFACTANT
Chair: G. Dimitriou, Patras, Greece; H. Verder, Holbaek, Denmark

• A stepwise therapeutic approach to RDS
   P. Rimensberger, Geneva, Switzerland

• Strategies for optimizing non-invasive ventilation and surfactant application
   R. Ramanathan, Los Angeles, USA

• European guidelines for the management of RDS
   D.G. Sweet, Belfast, Northern Ireland

1215Interactive Discussion


1245Lunch Break


1300Poster Session___

I      RESPIRATORY CARE, PULMONARY DISEASES AND BPD – Part 1
        Chair: A.B. te Pas, Leiden, The Netherlands; J.M. Solano, Bogota, Colombia

II      NUTRITION / GROWTH
         Chair: C. Härtel, Würzburg, Germany; William W. Hay Jr., Denver, USA

III      BRAIN AND NEURODEVELOPMENTAL OUTCOME
         Chair: C. Bührer, Berlin, Germany; N. Marlow, London, UK


1400WORKSHOP III

NEONATAL CARE IN DEVELOPING COUNTRIES
Chair: S. Lusyati, Jakarta, Indonesia; J. Smith, Tygerberg, South Africa

• Optimal ventilation and surfactant in very low birth weight infants in resource limited countries
   J. Smith, Tygerberg, South Africa

• Dilemmas of a neonatologist in developing countries
   R.K. Pejaver, Bangalore, India

• Challenges in neonatal care in resource poor settings
   J. Haddad, Beirut, Lebanon

1530Interactive Discussion


1600Coffee Break


1630WORKSHOP IV

OPTIMAL VENTILATORY STRATEGIES
Chair: C. Bührer, Berlin, Germany; C. Wright, Denver, USA

• Ventilatory strategies to prevent lung injury
   E. Bancalari, Miami, USA

• iNo for preterm infants: Evidence versus practice
   B. Thébaud, Ottawa, Canada

• HFOV in neonates: Still relevant in 2020?
   P. Rimensberger, Geneva, Switzerland

1800Interactive Discussion


1830Parallel Seminars___

A      How to get your manuscript rejected?
         E.S. Shinwell, Tsfat, Israel

B      How to design a clinical trial: From basics to pitfalls
         N. Modi, London, UK

C      Neonatal clinical pharmacology:
         A delicate combination of developmental biology and genetics
         J.N. van den Anker, Washington D.C., USA


1915Adjourn


WORKSHOPS
FRIDAY, OCTOBER 1, 2021

Parallel Sessions

  815WORKSHOP V

INTRAUTERINE INFLAMMATION AND INFECTION
Chair: S. Andersson, Helsinki, Finland; W.S. Park, Seoul, Korea

• Intrauterine inflammation and possible consequences for the preterm infant
   B.W. Kramer, Maastricht, The Netherlands

• Ureaplasma species: The hidden danger for preterm infants
   K. Glaser, Würzburg, Germany

• Fungal infections in the NICU: Preventive and therapeutic strategies
   E. Özek, Istanbul, Turkey

   945Interactive Discussion


1015Coffee Break


1045WORKSHOP VI

THE NEONATAL IMMUNE SYSTEM AND IMMUNODEFICIENCIES
Chair: B.W. Kramer, Maastricht, The Netherlands; B. Thébaud, Ottawa, Canada

• Modulation of the immune-microbiome interplay - any benefit for the newborn?
   C. Härtel, Würzburg, Germany

• When mother’s antibodies attack the neonate
   C. Bührer, Berlin, Germany

• Rare but dangerous: Immunodeficiencies of the newborn
   H. Morbach, Würzburg, Germany

1215Interactive Discussion


1245Lunch Break


1300Poster Session___

I      RESPIRATORY CARE, PULMONARY DISEASES AND BPD – Part 1
        Chair: A.B. te Pas, Leiden, The Netherlands; J.M. Solano, Bogota, Colombia

II      NUTRITION / GROWTH
         Chair: C. Härtel, Würzburg, Germany; William W. Hay Jr., Denver, USA

III      BRAIN AND NEURODEVELOPMENTAL OUTCOME
         Chair: C. Bührer, Berlin, Germany; N. Marlow, London, UK


1400WORKSHOP VII

STRATEGIES FOR A SUCCESSFUL FEEDING
Chair: W.W. Hay Jr., Denver, USA; I. Iskander, Cairo, Egypt

• Parenteral nutrition for immature preterm infants in the first week of life and beyond:
   Fluid intake, electrolytes and energy supply
   W.W. Hay Jr., Denver, USA

• Do we need fortifiers and nutritional supplements for preterm infants?
   N. Modi, London, UK

• Strategies for a successful feeding of the premature baby
   A. Liubsys, Vilnius, Lithuania

1530Interactive Discussion


1600Coffee Break


1630WORKSHOP VIII

PAIN, SEIZURES AND ROP
Chair: N. Marlow, London, UK; J.M. Solano, Bogota, Colombia

• Is there a way to measure pain perception in preterm infants?
   R. Slater, Oxford, UK

• The role of aEEg in seizure identification and prediction of outcome
   L.S. de Vries, Utrecht, The Netherlands

• Growth factors and Anti-VEGF in severe ROP: Has the time come?
   A. Hellström, Gothenburg, Sweden

 1800Interactive Discussion


 1830Parallel Seminars___

A      How to get your manuscript rejected?
         E.S. Shinwell, Tsfat, Israel

B      How to design a clinical trial: From basics to pitfalls
         N. Modi, London, UK

C      Neonatal clinical pharmacology:
         A delicate combination of developmental biology and genetics
         J.N. van den Anker, Washington D.C., USA


 1915Adjourn